Upcoming Pharma Projects in Hyderabad & Telangana

Projects India currently tracks 195 upcoming drugs and pharmaceuticals projects in Telangana, of which 145 are verified. Together, those with a recorded cost represent about Rs 7,243 crore in planned investment. Four projects were added to our database in the last 90 days — double the two added in the 90 days before that — signalling a modest but real acceleration in new plant activity across the state, spanning Hyderabad, Medak, Sangareddy and Nalgonda.

Telangana pharma pipeline at a glance

Largest upcoming pharma projects in Hyderabad and Telangana

The table below lists the highest-value projects in our drugs and pharmaceuticals project database for Telangana, drawn from verified records as of 19 October 2026.

Several patterns stand out. MSN Laboratories has three projects in the state, including one nearing completion at Mahbubnagar and a new pharmaceutical and R&D facility at Rangareddy. Genome Valley in Hyderabad is drawing high-value speciality investment, with Jamp Pharma Corporation committing Rs 250 crore to an R&D centre and Bharat Serums & Vaccines Limited already in active construction on a Rs 200 crore vaccines and injectables plant, with an expected completion of December 2026. The Hyderabad Pharma City cluster is also live, with Ferring Pharmaceuticals at Rs 200 crore in the approvals queue.

Where new pharma projects in Telangana are concentrated

Medak district dominates the Telangana pharma map with 57 projects — most of them clustered around the established Pashamylaram and Patancheru industrial estates. Nalgonda follows with 41 projects, driven by API and bulk drug expansions along the National Highway corridor. Hyderabad city itself accounts for 19 projects, skewed toward biologics, vaccines and formulations rather than bulk chemistry. Sangareddy (18 projects) has emerged as an expansion hub for mid-size API manufacturers including Pavan Drugs, Chromo Laboratories and Aurobindo. As the chart below shows, the geographic spread gives EPC contractors and equipment suppliers strong reason to look beyond Hyderabad city.

For B2B sales teams, this distribution matters in practical terms. Medak and Sangareddy projects tend to be API and bulk-drug expansions, which means demand for reactor vessels, solvent recovery systems, effluent treatment plant upgrades and utility infrastructure. Hyderabad city projects are more often biologics, formulations and R&D facilities, pulling in cleanroom contractors, HVAC specialists, fill-and-finish line suppliers and laboratory fitout firms. Targeting by district — not just by state — narrows the prospect list considerably.

Pipeline by stage: what the approvals backlog means for suppliers

The stage breakdown is critical intelligence for timing an approach, as the chart below shows.

With 111 projects under approvals and 27 more that have received approvals, well over half the tracked pipeline is still in pre-construction. These are the projects where an early-mover supplier — whether an EPC contractor, a process equipment vendor or a civil construction firm — can get on the vendor shortlist before budgets are locked. Projects at the Approvals Received stage, such as Aurobindo Pharma's Rs 125 crore Sangareddy expansion, are typically closest to issuing enquiries. The 33 projects already in Construction Started are actively buying: civil and structural work, mechanical equipment, piping, electrical and instrumentation packages are all live procurement at this stage. The four projects marked Nearly Completion are relevant for commissioning services, validation contractors and qualification support vendors.

Most active promoters across Telangana pharma projects

Knowing which promoters are running multiple projects simultaneously helps suppliers prioritise key accounts. As the chart below shows, a handful of companies are driving a disproportionate share of the project pipeline.

MSN Laboratories Private Limited leads by combined recorded value at about Rs 624 crore across three projects. Bio Vin Research Laboratories Private Limited is running five projects worth about Rs 177 crore. Optimus Drugs Private Limited has three projects totalling about Rs 248 crore. Multi-project promoters like these are worth treating as key accounts: a relationship with a procurement or projects team at MSN or Aurobindo (three projects, about Rs 140 crore) can unlock repeat business across locations. The VendorConnect supplier directory on Projects India lists verified contacts for several of these promoters.

Recent additions: new pharma projects in Telangana

Four projects were added to our database in the 90 days before 19 October 2026, all in the Sangareddy corridor:

• API Bulk Drug & Intermediates Mfg Unit — Expansion, Sangareddy | Chromo Laboratories India Private Limited | Rs 195 crore | Under Approvals. A significant capacity addition by an established Sangareddy API manufacturer, now in the approvals queue.
• Bulk Drugs & API Mfg Unit — Expansion, Bonthapally, Sangareddy | Granules India Limited | Rs 53 crore | Hold. Granules India's expansion is currently on hold; worth monitoring for a resumption trigger.
• Pharmaceutical Mfg Unit & R&D Centre at Green Pharma City, Mucherla, Rangareddy | MSN Laboratories Private Limited | Cost not yet recorded | Under Approvals. MSN's third project in the state adds a formulations and R&D dimension to its Telangana footprint. No cost has been recorded yet in our database.
• API and Intermediates Plant — Expansion, Sangareddy | Chemtech Acids & Chemicals Private Limited | Rs 20 crore | Hold. A smaller expansion, currently on hold.

The two projects on hold — Granules India and Chemtech — are worth keeping in view. Hold status in our database means activity has paused, not that the project has been cancelled. When conditions change, these tend to move quickly to procurement. For context, Yaari Healthcare LLP is one of the verified contacts listed in our directory relevant to the Telangana pharma space.

What this means for suppliers and contractors

The Telangana pharma project pipeline offers genuine near-term opportunity for several categories of supplier and contractor, but the right approach depends on stage.

• EPC and civil contractors should focus on the 33 Construction Started projects first — these are live sites with active civil, structural and utility packages. The Rs 153 crore Ichor Biologics expansion in Hyderabad and the Rs 200 crore MSN Lifesciences bulk drugs project in Nizamabad are examples. For pipeline development, the 27 Approvals Received projects are the next priority: Aurobindo's Sangareddy expansion is a named opportunity at Rs 125 crore.
• Process equipment vendors — reactor manufacturers, solvent recovery units, filtration systems — should map the Under Approvals queue now. Piramal's Rs 250 crore Medak expansion, Pavan Drugs' Rs 209 crore Sangareddy API unit and Optimus Drugs' Rs 166 crore Nalgonda expansion are all pre-FEED, meaning vendor engagement at this point can shape specifications.
• Cleanroom, HVAC and MEP contractors are most relevant to the Hyderabad city cluster, particularly Bharat Serums' vaccines plant and the Ferring Pharmaceuticals Pharma City project, both at Rs 200 crore.
• Commissioning, validation and qualification firms should be in contact with MSN Laboratories' Mahbubnagar project, which is marked Nearly Completion at Rs 550 crore — the highest-value project in this pipeline at that stage.
• Equipment and chemical suppliers targeting the Granules India or Chemtech hold projects should set a monitoring alert: resumption often comes with a short procurement cycle.

For a broader view of the contractor landscape serving this sector, see our guide to pharma EPC and construction contractors in India. Comparable pipeline analysis is available for upcoming pharma projects in Gujarat.

How to track these projects

The 195 upcoming pharma projects in Telangana described here are a subset of the 84,619 projects Projects India tracks nationally across all sectors. The drugs and pharmaceuticals project list for Telangana is updated continuously; new projects, stage changes and contact additions are logged as they are verified. Subscribers can filter by district, stage, cost range and promoter, set alerts for new additions, and export contact details for decision-makers directly linked to each project. A free sample project report is available to show the depth of data held on any individual project. For teams running tender searches in parallel, the live government tenders section covers related procurement notices. The full national pipeline across all industrial sectors is accessible through the industrial projects database for Telangana.